Sukumar Nagendran Insider Trading Transactions
FREE EMAIL WATCHDOG
Get free email notifications about insider trading for Sukumar Nagendran.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of Sukumar Nagendran. Sukumar Nagendran is Sr. VP & Chief Medical Officer in AveXis, Inc. ($AVXS) and Director in Solid Biosciences Inc. ($SLDB) and Director in Taysha Gene Therapies, Inc. ($TSHA).
Latest Insider Trading Transactions of Sukumar Nagendran
1 Week | 2 Weeks | 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | |
---|---|---|---|---|---|---|---|
No. of Purchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Value of Purchases ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
No. of Sales | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Value of Sales ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Sentiment: All, AVXS, SLDB, TSHA
Page: 1
Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
---|---|---|---|---|---|---|---|---|---|---|---|
Jun 21 2021 | TSHA | Taysha Gene Therap ... | Nagendran Sukumar | Director | Option Exercise | A | 25.04 | 15,500 | 388,120 | 15,500 | |
Sep 30 2020 | TSHA | Taysha Gene Therap ... | Nagendran Sukumar | Director | Option Exercise | C | 0.00 | 17,647 | 0 | 0 | |
Sep 30 2020 | TSHA | Taysha Gene Therap ... | Nagendran Sukumar | Director | Buy | C | 0.00 | 19,226 | 0 | 19,226 | 0 to 19.2 K |
Sep 25 2020 | TSHA | Taysha Gene Therap ... | Nagendran Sukumar | Director | Option Exercise | A | 20.00 | 31,000 | 620,000 | 31,000 | |
Jun 18 2020 | SLDB | Solid Biosciences ... | Nagendran Sukumar | Director | Option Exercise | A | 3.03 | 10,000 | 30,300 | 10,000 | |
Jun 18 2020 | SLDB | Solid Biosciences ... | Nagendran Sukumar | Director | Option Exercise | A | 3.03 | 30,000 | 90,900 | 30,000 | |
Jul 29 2019 | SLDB | Solid Biosciences ... | Nagendran Sukumar | Director | Grant | A | 4.65 | 32,258 | 150,000 | 34,258 | 2 K to 34.3 K (+1,612.90 %) |
Dec 17 2018 | SLDB | Solid Biosciences ... | Nagendran Sukumar | Director | Option Exercise | A | 23.58 | 17,240 | 406,519 | 17,240 | |
Sep 13 2018 | SLDB | Solid Biosciences ... | Nagendran Sukumar | Director | Option Exercise | A | 50.65 | 2,760 | 139,794 | 2,760 | |
May 15 2018 | AVXS | AveXis, Inc. | Nagendran Sukumar | Sr. VP & Chief Medi ... | Option Exercise | D | 0.00 | 9,906 | 0 | 0 | |
May 15 2018 | AVXS | AveXis, Inc. | Nagendran Sukumar | Sr. VP & Chief Medi ... | Option Exercise | A | 0.00 | 9,906 | 0 | 9,906 | |
May 15 2018 | AVXS | AveXis, Inc. | Nagendran Sukumar | Sr. VP & Chief Medi ... | Option Exercise | D | 133.80 | 15,000 | 2,007,000 | 0 | |
May 15 2018 | AVXS | AveXis, Inc. | Nagendran Sukumar | Sr. VP & Chief Medi ... | Option Exercise | D | 77.24 | 25,200 | 1,946,448 | 0 | |
May 15 2018 | AVXS | AveXis, Inc. | Nagendran Sukumar | Sr. VP & Chief Medi ... | Option Exercise | D | 42.61 | 37,750 | 1,608,528 | 0 | |
May 15 2018 | AVXS | AveXis, Inc. | Nagendran Sukumar | Sr. VP & Chief Medi ... | Option Exercise | D | 18.47 | 178,494 | 3,296,784 | 0 | |
May 15 2018 | AVXS | AveXis, Inc. | Nagendran Sukumar | Sr. VP & Chief Medi ... | Sell | D | 0.00 | 3,800 | 0 | 0 | 3.8 K to 0 (-100.00 %) |
Mar 27 2018 | AVXS | AveXis, Inc. | Nagendran Sukumar | Sr. VP & Chief Medi ... | Option Exercise | A | 133.80 | 15,000 | 2,007,000 | 15,000 | |
Mar 27 2018 | AVXS | AveXis, Inc. | Nagendran Sukumar | Sr. VP & Chief Medi ... | Grant | A | 0.00 | 3,800 | 0 | 3,800 | 0 to 3.8 K |
Mar 05 2018 | AVXS | AveXis, Inc. | Nagendran Sukumar | Sr. VP & Chief Medi ... | Option Exercise | M | 18.47 | 1,780 | 32,877 | 178,494 | |
Mar 05 2018 | AVXS | AveXis, Inc. | Nagendran Sukumar | Sr. VP & Chief Medi ... | Sell | S | 128.91 | 50 | 6,446 | 0 | 50 to 0 (-100.00 %) |
Mar 05 2018 | AVXS | AveXis, Inc. | Nagendran Sukumar | Sr. VP & Chief Medi ... | Sell | S | 127.99 | 408 | 52,220 | 50 | 458 to 50 (-89.08 %) |
Mar 05 2018 | AVXS | AveXis, Inc. | Nagendran Sukumar | Sr. VP & Chief Medi ... | Sell | S | 126.95 | 504 | 63,983 | 458 | 962 to 458 (-52.39 %) |
Mar 05 2018 | AVXS | AveXis, Inc. | Nagendran Sukumar | Sr. VP & Chief Medi ... | Sell | S | 125.72 | 449 | 56,448 | 962 | 1.4 K to 962 (-31.82 %) |
Mar 05 2018 | AVXS | AveXis, Inc. | Nagendran Sukumar | Sr. VP & Chief Medi ... | Sell | S | 124.29 | 175 | 21,751 | 1,411 | 1.6 K to 1.4 K (-11.03 %) |
Mar 05 2018 | AVXS | AveXis, Inc. | Nagendran Sukumar | Sr. VP & Chief Medi ... | Sell | S | 123.16 | 120 | 14,779 | 1,586 | 1.7 K to 1.6 K (-7.03 %) |
Mar 05 2018 | AVXS | AveXis, Inc. | Nagendran Sukumar | Sr. VP & Chief Medi ... | Sell | S | 121.51 | 74 | 8,992 | 1,706 | 1.8 K to 1.7 K (-4.16 %) |
Mar 05 2018 | AVXS | AveXis, Inc. | Nagendran Sukumar | Sr. VP & Chief Medi ... | Buy | M | 18.47 | 1,780 | 32,877 | 1,780 | 0 to 1.8 K |
Feb 05 2018 | AVXS | AveXis, Inc. | Nagendran Sukumar | Sr. VP & Chief Medi ... | Option Exercise | M | 18.47 | 1,780 | 32,877 | 180,274 | |
Feb 05 2018 | AVXS | AveXis, Inc. | Nagendran Sukumar | Sr. VP & Chief Medi ... | Sell | S | 122.83 | 17 | 2,088 | 0 | 17 to 0 (-100.00 %) |
Feb 05 2018 | AVXS | AveXis, Inc. | Nagendran Sukumar | Sr. VP & Chief Medi ... | Sell | S | 120.79 | 258 | 31,164 | 17 | 275 to 17 (-93.82 %) |
Feb 05 2018 | AVXS | AveXis, Inc. | Nagendran Sukumar | Sr. VP & Chief Medi ... | Sell | S | 118.96 | 3 | 357 | 275 | 278 to 275 (-1.08 %) |
Feb 05 2018 | AVXS | AveXis, Inc. | Nagendran Sukumar | Sr. VP & Chief Medi ... | Sell | S | 118.01 | 501 | 59,123 | 278 | 779 to 278 (-64.31 %) |
Feb 05 2018 | AVXS | AveXis, Inc. | Nagendran Sukumar | Sr. VP & Chief Medi ... | Sell | S | 117.12 | 1,001 | 117,237 | 779 | 1.8 K to 779 (-56.24 %) |
Feb 05 2018 | AVXS | AveXis, Inc. | Nagendran Sukumar | Sr. VP & Chief Medi ... | Buy | M | 18.47 | 1,780 | 32,877 | 1,780 | 0 to 1.8 K |
Jan 04 2018 | AVXS | AveXis, Inc. | Nagendran Sukumar | Sr. VP & Chief Medi ... | Option Exercise | M | 18.47 | 1,780 | 32,877 | 182,054 | |
Jan 04 2018 | AVXS | AveXis, Inc. | Nagendran Sukumar | Sr. VP & Chief Medi ... | Sell | S | 110.21 | 684 | 75,384 | 0 | 684 to 0 (-100.00 %) |
Jan 04 2018 | AVXS | AveXis, Inc. | Nagendran Sukumar | Sr. VP & Chief Medi ... | Sell | S | 109.42 | 1,096 | 119,924 | 684 | 1.8 K to 684 (-61.57 %) |
Jan 04 2018 | AVXS | AveXis, Inc. | Nagendran Sukumar | Sr. VP & Chief Medi ... | Buy | M | 18.47 | 1,780 | 32,877 | 1,780 | 0 to 1.8 K |
Dec 05 2017 | AVXS | AveXis, Inc. | Nagendran Sukumar | Sr. VP & Chief Medi ... | Option Exercise | M | 18.47 | 1,780 | 32,877 | 183,834 | |
Dec 05 2017 | AVXS | AveXis, Inc. | Nagendran Sukumar | Sr. VP & Chief Medi ... | Sell | S | 95.81 | 135 | 12,934 | 0 | 135 to 0 (-100.00 %) |
Dec 05 2017 | AVXS | AveXis, Inc. | Nagendran Sukumar | Sr. VP & Chief Medi ... | Sell | S | 94.92 | 1,327 | 125,959 | 135 | 1.5 K to 135 (-90.77 %) |
Dec 05 2017 | AVXS | AveXis, Inc. | Nagendran Sukumar | Sr. VP & Chief Medi ... | Sell | S | 93.72 | 318 | 29,803 | 1,462 | 1.8 K to 1.5 K (-17.87 %) |
Dec 05 2017 | AVXS | AveXis, Inc. | Nagendran Sukumar | Sr. VP & Chief Medi ... | Buy | M | 18.47 | 1,780 | 32,877 | 1,780 | 0 to 1.8 K |
Nov 03 2017 | AVXS | AveXis, Inc. | Nagendran Sukumar | Sr. VP & Chief Medi ... | Option Exercise | M | 18.47 | 1,780 | 32,877 | 185,614 | |
Nov 03 2017 | AVXS | AveXis, Inc. | Nagendran Sukumar | Sr. VP & Chief Medi ... | Sell | S | 106.26 | 70 | 7,438 | 0 | 70 to 0 (-100.00 %) |
Nov 03 2017 | AVXS | AveXis, Inc. | Nagendran Sukumar | Sr. VP & Chief Medi ... | Sell | S | 105.02 | 205 | 21,529 | 70 | 275 to 70 (-74.55 %) |
Nov 03 2017 | AVXS | AveXis, Inc. | Nagendran Sukumar | Sr. VP & Chief Medi ... | Sell | S | 104.06 | 149 | 15,505 | 275 | 424 to 275 (-35.14 %) |
Nov 03 2017 | AVXS | AveXis, Inc. | Nagendran Sukumar | Sr. VP & Chief Medi ... | Sell | S | 102.00 | 42 | 4,284 | 424 | 466 to 424 (-9.01 %) |
Nov 03 2017 | AVXS | AveXis, Inc. | Nagendran Sukumar | Sr. VP & Chief Medi ... | Sell | S | 100.70 | 631 | 63,542 | 466 | 1.1 K to 466 (-57.52 %) |
Nov 03 2017 | AVXS | AveXis, Inc. | Nagendran Sukumar | Sr. VP & Chief Medi ... | Sell | S | 100.05 | 431 | 43,122 | 1,097 | 1.5 K to 1.1 K (-28.21 %) |
Nov 03 2017 | AVXS | AveXis, Inc. | Nagendran Sukumar | Sr. VP & Chief Medi ... | Sell | S | 98.51 | 252 | 24,825 | 1,528 | 1.8 K to 1.5 K (-14.16 %) |
Nov 03 2017 | AVXS | AveXis, Inc. | Nagendran Sukumar | Sr. VP & Chief Medi ... | Buy | M | 18.47 | 1,780 | 32,877 | 1,780 | 0 to 1.8 K |
Oct 03 2017 | AVXS | AveXis, Inc. | Nagendran Sukumar | Sr. VP & Chief Medi ... | Option Exercise | M | 18.47 | 1,780 | 32,877 | 187,394 | |
Oct 03 2017 | AVXS | AveXis, Inc. | Nagendran Sukumar | Sr. VP & Chief Medi ... | Sell | S | 99.26 | 170 | 16,874 | 0 | 170 to 0 (-100.00 %) |
Oct 03 2017 | AVXS | AveXis, Inc. | Nagendran Sukumar | Sr. VP & Chief Medi ... | Sell | S | 98.77 | 385 | 38,026 | 170 | 555 to 170 (-69.37 %) |
Oct 03 2017 | AVXS | AveXis, Inc. | Nagendran Sukumar | Sr. VP & Chief Medi ... | Sell | S | 96.98 | 587 | 56,927 | 555 | 1.1 K to 555 (-51.40 %) |
Oct 03 2017 | AVXS | AveXis, Inc. | Nagendran Sukumar | Sr. VP & Chief Medi ... | Sell | S | 96.05 | 638 | 61,280 | 1,142 | 1.8 K to 1.1 K (-35.84 %) |
Oct 03 2017 | AVXS | AveXis, Inc. | Nagendran Sukumar | Sr. VP & Chief Medi ... | Buy | M | 18.47 | 1,780 | 32,877 | 1,780 | 0 to 1.8 K |
Sep 05 2017 | AVXS | AveXis, Inc. | Nagendran Sukumar | Sr. VP & Chief Medi ... | Option Exercise | M | 18.47 | 1,780 | 32,877 | 189,174 | |
Sep 05 2017 | AVXS | AveXis, Inc. | Nagendran Sukumar | Sr. VP & Chief Medi ... | Sell | S | 93.91 | 574 | 53,904 | 0 | 574 to 0 (-100.00 %) |
Sep 05 2017 | AVXS | AveXis, Inc. | Nagendran Sukumar | Sr. VP & Chief Medi ... | Sell | S | 92.93 | 1,206 | 112,074 | 574 | 1.8 K to 574 (-67.75 %) |
Sep 05 2017 | AVXS | AveXis, Inc. | Nagendran Sukumar | Sr. VP & Chief Medi ... | Buy | M | 18.47 | 1,780 | 32,877 | 1,780 | 0 to 1.8 K |
Aug 03 2017 | AVXS | AveXis, Inc. | Nagendran Sukumar | Sr. VP & Chief Medi ... | Option Exercise | M | 18.47 | 1,780 | 32,877 | 190,954 | |
Aug 03 2017 | AVXS | AveXis, Inc. | Nagendran Sukumar | Sr. VP & Chief Medi ... | Sell | S | 92.75 | 17 | 1,577 | 0 | 17 to 0 (-100.00 %) |
Aug 03 2017 | AVXS | AveXis, Inc. | Nagendran Sukumar | Sr. VP & Chief Medi ... | Sell | S | 91.92 | 696 | 63,976 | 17 | 713 to 17 (-97.62 %) |
Aug 03 2017 | AVXS | AveXis, Inc. | Nagendran Sukumar | Sr. VP & Chief Medi ... | Sell | S | 91.24 | 1,067 | 97,353 | 713 | 1.8 K to 713 (-59.94 %) |
Aug 03 2017 | AVXS | AveXis, Inc. | Nagendran Sukumar | Sr. VP & Chief Medi ... | Buy | M | 18.47 | 1,780 | 32,877 | 1,780 | 0 to 1.8 K |
Jun 02 2017 | AVXS | AveXis, Inc. | Nagendran Sukumar | Sr. VP & Chief Medi ... | Option Exercise | M | 18.47 | 1,780 | 32,877 | 194,514 | |
Jun 02 2017 | AVXS | AveXis, Inc. | Nagendran Sukumar | Sr. VP & Chief Medi ... | Sell | S | 71.91 | 170 | 12,225 | 0 | 170 to 0 (-100.00 %) |
Jun 02 2017 | AVXS | AveXis, Inc. | Nagendran Sukumar | Sr. VP & Chief Medi ... | Sell | S | 71.19 | 977 | 69,553 | 170 | 1.1 K to 170 (-85.18 %) |
Jun 02 2017 | AVXS | AveXis, Inc. | Nagendran Sukumar | Sr. VP & Chief Medi ... | Sell | S | 70.20 | 633 | 44,437 | 1,147 | 1.8 K to 1.1 K (-35.56 %) |
Jun 02 2017 | AVXS | AveXis, Inc. | Nagendran Sukumar | Sr. VP & Chief Medi ... | Buy | M | 18.47 | 1,780 | 32,877 | 1,780 | 0 to 1.8 K |
May 12 2017 | AVXS | AveXis, Inc. | Nagendran Sukumar | Sr. VP & Chief Medi ... | Option Exercise | A | 77.24 | 25,200 | 1,946,448 | 25,200 | |
May 02 2017 | AVXS | AveXis, Inc. | Nagendran Sukumar | Sr. VP & Chief Medi ... | Option Exercise | M | 18.47 | 1,780 | 32,877 | 196,294 | |
May 02 2017 | AVXS | AveXis, Inc. | Nagendran Sukumar | Sr. VP & Chief Medi ... | Sell | S | 82.58 | 22 | 1,817 | 0 | 22 to 0 (-100.00 %) |
May 02 2017 | AVXS | AveXis, Inc. | Nagendran Sukumar | Sr. VP & Chief Medi ... | Sell | S | 81.91 | 576 | 47,180 | 22 | 598 to 22 (-96.32 %) |
May 02 2017 | AVXS | AveXis, Inc. | Nagendran Sukumar | Sr. VP & Chief Medi ... | Sell | S | 81.11 | 1,182 | 95,872 | 598 | 1.8 K to 598 (-66.40 %) |
May 02 2017 | AVXS | AveXis, Inc. | Nagendran Sukumar | Sr. VP & Chief Medi ... | Buy | M | 18.47 | 1,780 | 32,877 | 1,780 | 0 to 1.8 K |
Apr 05 2017 | AVXS | AveXis, Inc. | Nagendran Sukumar | Sr. VP & Chief Medi ... | Option Exercise | M | 18.47 | 1,781 | 32,895 | 198,074 | |
Apr 05 2017 | AVXS | AveXis, Inc. | Nagendran Sukumar | Sr. VP & Chief Medi ... | Sell | S | 76.13 | 1,781 | 135,588 | 0 | 1.8 K to 0 (-100.00 %) |
Apr 05 2017 | AVXS | AveXis, Inc. | Nagendran Sukumar | Sr. VP & Chief Medi ... | Buy | M | 18.47 | 1,781 | 32,895 | 1,781 | 0 to 1.8 K |
Jun 22 2016 | AVXS | AveXis, Inc. | Nagendran Sukumar | Sr. VP & Chief Medi ... | Option Exercise | A | 42.61 | 37,750 | 1,608,528 | 37,750 |
Page: 1